Antibiotic	O
-	O
induced	O
persistence	O
of	O
cytotoxic	O
Staphylococcus	O
aureus	O
in	O
non	B-Cell
-	I-Cell
phagocytic	I-Cell
cells	I-Cell
.	O

OBJECTIVES	O
:	O

After	O
infection	O
of	O
non	B-Cell
-	I-Cell
phagocytic	I-Cell
cells	I-Cell
,	O
some	O
Staphylococcus	O
aureus	O
strains	B-Cell
are	O
able	O
to	O
survive	O
and	O
kill	O
their	O
host	O
cells	B-Cell
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
action	O
of	O
various	O
antibiotics	O
on	O
the	O
survival	O
of	O
host	O
cells	B-Cell
and	O
/	O
or	O
intracellular	B-Immaterial_anatomical_entity
S	O
.	O
aureus	O
.	O

METHODS	O
:	O

Murine	O
keratinocyte	B-Cell
(	O
PAM212	B-Cell
)	O
and	O
fibroblast	B-Cell
(	I-Cell
mKSA	I-Cell
)	I-Cell
cell	I-Cell
lines	I-Cell
were	O
infected	O
with	O
cytotoxic	O
S	O
.	O
aureus	O
and	O
cultured	O
in	O
the	O
presence	O
of	O
various	O
antibiotics	O
at	O
graded	O
concentrations	O
.	O

The	O
viability	O
of	O
host	O
cells	B-Cell
was	O
measured	O
24	O
h	O
after	O
infection	O
.	O

To	O
determine	O
the	O
bacterial	O
viability	O
within	O
host	O
cells	B-Cell
,	O
cellular	B-Organism_substance
lysates	I-Organism_substance
were	O
prepared	O
and	O
colony	B-Cell
forming	O
units	O
were	O
quantified	O
using	O
a	O
spiral	O
plater	O
.	O

Host	O
cells	B-Cell
infected	O
with	O
fluorescein	O
isothiocyanate	O
(	O
FITC	O
)	O
-	O
labelled	O
S	O
.	O
aureus	O
were	O
analysed	O
by	O
flow	O
cytometry	O
and	O
microscopy	O
to	O
determine	O
the	O
subcellular	B-Cellular_component
localization	O
S	O
.	O
aureus	O
.	O

RESULTS	O
:	O

Oxacillin	O
,	O
vancomycin	O
,	O
gentamicin	O
,	O
ciprofloxacin	O
and	O
trimethoprim	O
/	O
sulfamethoxazole	O
did	O
not	O
rescue	O
host	O
cells	B-Cell
from	O
cell	B-Cell
death	O
induced	O
by	O
intracellular	B-Immaterial_anatomical_entity
S	O
.	O
aureus	O
.	O

In	O
contrast	O
,	O
linezolid	O
,	O
rifampicin	O
,	O
azithromycin	O
,	O
clindamycin	O
,	O
erythromycin	O
and	O
quinupristin	O
/	O
dalfopristin	O
suppressed	O
the	O
cytotoxic	O
action	O
of	O
S	O
.	O
aureus	O
.	O

After	O
withdrawal	O
of	O
antibiotics	O
,	O
intracellular	B-Immaterial_anatomical_entity
S	O
.	O
aureus	O
regained	O
cytotoxic	O
activity	O
and	O
killed	O
their	O
host	O
cells	B-Cell
.	O

Only	O
rifampicin	O
was	O
able	O
to	O
eliminate	O
intracellular	B-Immaterial_anatomical_entity
S	O
.	O
aureus	O
completely	O
within	O
72	O
h	O
.	O

In	O
contrast	O
,	O
clindamycin	O
,	O
azithromycin	O
and	O
linezolid	O
induced	O
a	O
state	O
of	O
intracellular	B-Immaterial_anatomical_entity
persistence	O
of	O
viable	O
S	O
.	O
aureus	O
.	O

CONCLUSIONS	O
:	O

Antibiotics	O
commonly	O
used	O
for	O
the	O
management	O
of	O
S	O
.	O
aureus	O
infections	O
appear	O
to	O
create	O
a	O
niche	O
for	O
invasive	O
intracellular	B-Immaterial_anatomical_entity
S	O
.	O
aureus	O
,	O
which	O
may	O
play	O
an	O
important	O
role	O
for	O
persistence	O
and	O
recurrence	O
of	O
infection	O
.	O

Because	O
of	O
its	O
unique	O
ability	O
to	O
eliminate	O
intracellular	B-Immaterial_anatomical_entity
S	O
.	O
aureus	O
,	O
rifampicin	O
appears	O
to	O
be	O
valuable	O
for	O
the	O
treatment	O
of	O
invasive	O
S	O
.	O
aureus	O
infections	O
.	O

